• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Reunion Neuroscience Inc. - Common Shares (NQ: REUN )

    N/A UNCHANGED
    Last Price Updated: 3:59 PM EDT, Jul 31, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.110 (83)
    Ask (Size) 1.130 (15)
    Prev. Close 1.120
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference
    From Reunion Neuroscience Inc.
    Via GlobeNewswire
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published 
    Via Benzinga

    Performance

    More News

    Read More
    Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
    Via Benzinga
    Recap: Reunion Neuroscience Q4 Earnings
    Via Benzinga
    Reunion Neuroscience: Q4 Earnings Insights
    Via Benzinga
    What's Going On With Reunion Neuroscience Stock Today
    Via Benzinga
    Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
    Via Benzinga
    Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
    Via Benzinga
    Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
    Via Benzinga
    Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
    Via Benzinga
    Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
    Via Benzinga
    The 7 Most Promising Penny Stocks to Buy in June
    Via InvestorPlace
    Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More
    Via Benzinga
    Traders Insights: Stocks Making Moves After Announcing News: REUN, WLDS, SPRC, QBTS
    Via AB Newswire
    Reunion Neuroscience Announces $13.1M Take-Private Transaction With Biotech Investment Firm
    Via Benzinga
    Nasdaq Surges Over 1%; Dollar General Lowers Annual Guidance
    Via Benzinga
    Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    US Stocks Turn Higher; ISM Manufacturing PMI Drops In May
    Via Benzinga
    REUN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reunion Neuroscience Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
    Via Benzinga
    Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed
    Via Benzinga
    Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
    Via Benzinga
    Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.